Literature DB >> 21063845

Effect of Mad2 on paclitaxel-induced cell death in ovarian cancer cells.

Xing Hao1, Zhigang Zhou, Shuangmei Ye, Ting Zhou, Yunping Lu, Ding Ma, Shixuan Wang.   

Abstract

In this article, the status of spindle assembly checkpoint and the alteration of its major component, Mad2 protein level were examined in A2780 and SKOV3 ovarian cancer cell lines. Recombinant eukaryotic expression plasmid pEGFP-Mad2 was transfected into paclitaxel-resistant SKOV3 cells and Mad2 protein was knocked down by Mad2-specific siRNA in paclitaxel-sensitive A2780 cells. Then the expression level of Mad2 gene was detected by Western blotting. Flow cytometry revealed that SKOV3 cells were not fully arrested in G(2)/M phase in contrast to A2780 cells in the presence of paclitaxel. However, paclitaxel sensitivity assay showed that sensitivity to paclitaxel was reversed after the transfection in both cell lines in terms of number of cells arrested at G(2)/M phase and the expression of Bcl-2 was significantly changed. These results suggest that weakened spindle checkpoint with reduced expression of Mad2 is associated with resistance to paclitaxel in ovarian cells and Bcl-2 may be involved in this process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063845     DOI: 10.1007/s11596-010-0553-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  25 in total

Review 1.  Attachment and tension in the spindle assembly checkpoint.

Authors:  Jun Zhou; Joyce Yao; Harish C Joshi
Journal:  J Cell Sci       Date:  2002-09-15       Impact factor: 5.285

Review 2.  Spindle regulation: Mps1 flies into new areas.

Authors:  Harold A Fisk; Mark Winey
Journal:  Curr Biol       Date:  2004-12-29       Impact factor: 10.834

3.  Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.

Authors:  Jan Kovár; Marie Ehrlichová; Barbora Smejkalová; Ilaria Zanardi; Iwao Ojima; Ivan Gut
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

4.  Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis.

Authors:  R K Srivastava; Q S Mi; J M Hardwick; D L Longo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 5.  Microtubule assembly dynamics: an attractive target for anticancer drugs.

Authors:  Parminder Singh; Krishnan Rathinasamy; Renu Mohan; Dulal Panda
Journal:  IUBMB Life       Date:  2008-06       Impact factor: 3.885

6.  Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint.

Authors:  Tamotsu Sudo; Masayuki Nitta; Hideyuki Saya; Naoto T Ueno
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

Review 7.  Taxanes, microtubules and chemoresistant breast cancer.

Authors:  Barbara T McGrogan; Breege Gilmartin; Desmond N Carney; Amanda McCann
Journal:  Biochim Biophys Acta       Date:  2007-11-12

8.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

Review 9.  Drug insight: Use of docetaxel in prostate and urothelial cancers.

Authors:  Niklas J Mackler; Kenneth J Pienta
Journal:  Nat Clin Pract Urol       Date:  2005-02

10.  Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.

Authors:  Eric A Lee; Michael K Keutmann; Melissa L Dowling; Eleanor Harris; Gordon Chan; Gary D Kao
Journal:  Mol Cancer Ther       Date:  2004-06       Impact factor: 6.261

View more
  7 in total

Review 1.  Mitotic checkpoint defects: en route to cancer and drug resistance.

Authors:  Sinjini Sarkar; Pranab Kumar Sahoo; Sutapa Mahata; Ranita Pal; Dipanwita Ghosh; Tanuma Mistry; Sushmita Ghosh; Tanmoy Bera; Vilas D Nasare
Journal:  Chromosome Res       Date:  2021-01-06       Impact factor: 5.239

2.  Mutation of the retinoblastoma tumor suppressor gene sensitizes cancers to mitotic inhibitor induced cell death.

Authors:  Jiong Zhao; Zhenyu Zhang; Yang Liao; Wei Du
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

3.  Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints.

Authors:  Stephan C Jahn; Patrick E Corsino; Bradley J Davis; Mary E Law; Peter Nørgaard; Brian K Law
Journal:  J Cell Sci       Date:  2013-01-15       Impact factor: 5.285

4.  Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.

Authors:  J Bargiela-Iparraguirre; L Prado-Marchal; N Pajuelo-Lozano; B Jiménez; R Perona; I Sánchez-Pérez
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.

Authors:  Tara Byrne; Helen G Coleman; Janine A Cooper; W Glenn McCluggage; Amanda McCann; Fiona Furlong
Journal:  Oncotarget       Date:  2017-06-08

Review 6.  Mechanisms of Taxane Resistance.

Authors:  Sara M Maloney; Camden A Hoover; Lorena V Morejon-Lasso; Jenifer R Prosperi
Journal:  Cancers (Basel)       Date:  2020-11-10       Impact factor: 6.639

7.  Mitotic slippage and the subsequent cell fates after inhibition of Aurora B during tubulin-binding agent-induced mitotic arrest.

Authors:  Yasuo Tsuda; Makoto Iimori; Yuichiro Nakashima; Ryota Nakanishi; Koji Ando; Kippei Ohgaki; Hiroyuki Kitao; Hiroshi Saeki; Eiji Oki; Yoshihiko Maehara
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.